Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants

Published:2014-10 Issue:10 Volume:12 Page:1636-1646
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Schmitz E. M. H.¹²³,Boonen K.¹,van den Heuvel D. J. A.¹,van Dongen J. L. J.²³,Schellings M. W. M.⁴,Emmen J. M. A.⁴,van der Graaf F.³⁴,Brunsveld L.²³,van de Kerkhof D.¹³

Affiliation:

1. Clinical Laboratory; Catharina Hospital; Eindhoven The Netherlands

2. Laboratory of Chemical Biology and Institute of Complex Molecular Systems; Department of Biomedical Engineering; Eindhoven University of Technology; Eindhoven The Netherlands

3. Expert Center Clinical Chemistry Eindhoven; Eindhoven The Netherlands

4. Clinical Laboratory; Máxima Medical Center Veldhoven; Veldhoven the Netherlands

Funder

Noyon Foundation

Netherlands Society for Clinical Chemistry and Laboratory Medicine

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12702/fullpdf

Reference33 articles.

1. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects;Stangier;Br J Clin Pharmacol,2007

2. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate;Stangier;Clin Pharmacokinet,2008

3. Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents;Bassand;Europace,2012

4. Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity;Ryn;Thromb Haemost,2010

5. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;Ageno;Chest,2012

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability of Hemostasis Parameters in Whole Blood, Plasma, and Frozen Plasma: Literature Review and Recommendations of the SFTH (French Society of Thrombosis and Haemostasis);Seminars in Thrombosis and Hemostasis;2024-08-30

2. Dried plasma spot as an innovative approach to therapeutic drug monitoring of apixaban: Development and validation of a novel liquid chromatography‐tandem mass spectrometry method;Journal of Mass Spectrometry;2024-08-26

3. Pharmacokinetics of single‐dose rivaroxaban under fed state in obese vs. non‐obese subjects: An open‐label controlled clinical trial (RIVOBESE‐PK);Clinical and Translational Science;2024-06

4. Does in vitro hemolysis affect measurements of plasma apixaban concentration by UPLC‐MS and anti‐Xa assay?;International Journal of Laboratory Hematology;2024-05-29

5. Development and Validation of a Quantification Method for Direct Oral Anticoagulants from Capillary Blood Using Volumetric Absorptive Microsampling and Online Spe-Lc-Ms;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3